Query author contributions in Reactome
Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.
If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.
Details on Person The A1 receptor (Libert F et al, 1992) has an inhibitory fun...
| Class:Id | Summation:418940 |
|---|---|
| _displayName | The A1 receptor (Libert F et al, 1992) has an inhibitory fun... |
| _timestamp | 2009-05-28 14:36:40 |
| created | [InstanceEdit:418916] Jassal, Bijay, 2009-04-27 |
| modified | [InstanceEdit:418948] Jassal, Bijay, 2009-04-27 [InstanceEdit:422353] Jassal, Bijay, 2009-05-28 |
| text | The A1 receptor (Libert F et al, 1992) has an inhibitory function on most of the tissues in which it is expressed. In the brain, it slows metabolic activity and also decreases heart rate. The A1, together with A2a receptors, are believed to play a role in regulating myocardial oxygen consumption and coronary blood flow. The A3 receptor (Salvatore CA et al, 1993) mediates a sustained cardioprotective function during cardiac ischemia and it is involved in the inhibition of neutrophil degranulation in neutrophil-mediated tissue injury. Both the A1 and A3 receptors mediate their effects by coupling with the G protein alpha i subunit which inhibits adenylyl cyclase (Wise A et al, 1999). |
| (summation) | [Reaction:418904] A1 and A3 receptors bind adenosine [Homo sapiens] |
| [Change default viewing format] | |
No pathways have been reviewed or authored by The A1 receptor (Libert F et al, 1992) has an inhibitory fun... (418940)
